Dr Thomas Jung: Ledger

Stories naming Dr Thomas Jung. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Role	Organisation	Sources
Chief Medical Officer	Inflazome	SmartCompany

Unnamed stage $63m

Queensland biotech startup Inflazome raises $63 million to change the way we treat Alzheimer’s

Queensland biotech firm Inflazome has secured a large funding round led by Forbian to advance its anti-inflammatory drug candidates into clinical trials, and has hired a chief medical officer to lead that development.

SmartCompany Tue 4 Dec 2018 Inflazome Novartis Venture Fund UniQuest University of Queensland Forbion Fountain Healthcare Partners Longitude Capital Novartis Matt Cooper Dr Thomas Jung

Also SmartCompany

Dr Thomas Jung

Roles

Coverage

Queensland biotech startup Inflazome raises $63 million to change the way we treat Alzheimer’s